FYERS
Astal Laboratories69.61
-0.01 (-0.97%)

Astal Laboratories Share Price

69.61-0.01 (-0.97%)
-15.01% past 1 Year

Corporate filings & documents

Announcements

Submission of Intimation under SEBI (PIT) Regulations 2015.
1 week ago
Submission of Intimation under SEBI (PIT) Regulations 2015.
1 week ago
Submission of newspaper publication of AGM Notice.
1 week ago
Submission of newspaper publication of AGM Notice.
1 week ago
Attached.
2 weeks ago
Attached.
2 weeks ago
Submission of 33rd AGM Notice.
2 weeks ago
Submission of 33rd AGM Notice.
2 weeks ago
Submission of Annual Report for the financial year ended March 31 2026.
2 weeks ago
Submission of Annual Report for the financial year ended March 31 2026.
2 weeks ago
Submission of Intimation of AGM.
2 weeks ago
Submission of Intimation of AGM.
2 weeks ago
Submission of intimation of Appointment of Cost Auditor.
2 weeks ago
Submission of intimation of Appointment of Cost Auditor.
2 weeks ago
Submission of outcome of the meeting of the Board of Directors.
2 weeks ago
Submission of outcome of the meeting of the Board of Directors.
2 weeks ago
Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve 1. To Consider & to approve the Notice of 33rd Annual General Meeting of the Company along with fixing the day date time and Venue of Annual General Meeting of the Company;2. To Approve Board Report along with all other necessary Annexure for the financial year ended March 31 2026;3. To Appoint Scrutinizer to scrutinize voting during the AGM and remote e-voting;4. Any other matter with the permission of chair.
3 weeks ago
Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve 1. To Consider & to approve the Notice of 33rd Annual General Meeting of the Company along with fixing the day date time and Venue of Annual General Meeting of the Company;2. To Approve Board Report along with all other necessary Annexure for the financial year ended March 31 2026;3. To Appoint Scrutinizer to scrutinize voting during the AGM and remote e-voting;4. Any other matter with the permission of chair.
3 weeks ago
Submission of Newspaper publication of financial results for the quarter ended 30th June 2026.
1 month ago
Submission of Newspaper publication of financial results for the quarter ended 30th June 2026.
1 month ago
Submission of Statement of Deviation & Variation
1 month ago
Submission of Statement of Deviation & Variation
1 month ago
Submission of Financial Results for the quarter ended June 30 2026.
1 month ago
Submission of Financial Results for the quarter ended June 30 2026.
1 month ago
Submission of Outcome of Board Meeting.
1 month ago
Submission of Outcome of Board Meeting.
1 month ago
Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Prior intimation of Board meeting to approve quarterly financial results for the quarter ended 30th June 2026.
1 month ago
Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Prior intimation of Board meeting to approve quarterly financial results for the quarter ended 30th June 2026.
1 month ago
Submission of Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
2 months ago
Submission of Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
2 months ago
Submission of Trading Window Closure Intimation.
2 months ago
Submission of Trading Window Closure Intimation.
2 months ago
Outcome of board meeting held on today i.e. 29th June 2026.
2 months ago
Outcome of board meeting held on today i.e. 29th June 2026.
2 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Astal Laboratories Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L74120UP1993PLC015605</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>13.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Mahendra Kumar <br/> Designation: Company Secretary and Compliance officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: BALAYOGISWARA RAO PEDDINTI <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 22/06/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
3 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Astal Laboratories Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L74120UP1993PLC015605</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>13.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Mahendra Kumar <br/> Designation: Company Secretary and Compliance officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: BALAYOGISWARA RAO PEDDINTI <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 22/06/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
3 months ago
Newspaper publication.
3 months ago
Newspaper publication.
3 months ago
Submission of newspaper publication for financial results for the quarter and year ended March 2026.
3 months ago
Submission of newspaper publication for financial results for the quarter and year ended March 2026.
3 months ago
Intimation of authorization of KMPs under regulation 30 (5) of SEBI (LODR) Regulations 2015.
3 months ago
Internal Auditor appointment for the financial year 2026-27.
3 months ago
Financial Results for quarter and year ended March 31 2026
3 months ago
Statement of Deviation and variation
3 months ago
Statement of Deviation and variation
3 months ago
Audited standalone and consolidated financial results for the quarter and financial year ended March. 31 2026.
3 months ago
Audited standalone and consolidated financial results for the quarter and financial year ended March. 31 2026.
3 months ago
Outcome of Board Meeting held on Saturday 30th May 2026.
3 months ago
Annual Secretarial Compliance Report for the period March 31 2026.
3 months ago
Annual Secretarial Compliance Report for the period March 31 2026.
3 months ago

Annual reports

FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Astal Laboratories Ltd Share Price Today

The Astal Laboratories Ltd share price today is ₹70.00. During the trading session, the Astal Laboratories Ltd share price opened at ₹76.90 and recorded an intraday high of ₹77.40 and a low of ₹62.80. Last closing price was ₹76.90. Over the past 52 weeks, the Astal Laboratories Ltd share price has ranged between ₹60.45 and ₹103.20. The current Astal Laboratories Ltd stock price reflects real-time market activity based on executed trades on the exchange.